Nasal vaccine additive linked to improved flu survival in mice over 100 days
A nasal vaccine additive was linked to improved survival in mice infected with flu 100 days after treatment. The finding comes from lab research on respiratory virus protection.
Why it matters
This may inform future vaccine strategies, though the evidence is from animal studies.
Study type and population
The research was conducted on mice and involved a nasal vaccine additive tested for its effect on flu survival.
Common questions
What kind of study was this?
The study was conducted in mice and involved testing a nasal vaccine additive for its effect on flu survival.
Sources
- Nasal vaccine additive improves flu survival in mice even 100 days after treatment MedicalXpress · medicalxpress.com
Headlines and links belong to the publishers listed above. The summary above is written by The Health Brief; see how this works.
